Vera-Puente, O., Rodríguez-Antolín, C., Salgado-Figueroa, A., Michalska, P., Pernia, O., Reid, B. M., . . . Ibáñez de Cáceres, I. (2018). MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.
Citación estilo ChicagoVera-Puente, Olga, et al. MAFG Is a Potential Therapeutic Target to Restore Chemosensitivity in Cisplatin-resistant Cancer Cells By Increasing Reactive Oxygen Species. 2018.
Cita MLAVera-Puente, Olga, et al. MAFG Is a Potential Therapeutic Target to Restore Chemosensitivity in Cisplatin-resistant Cancer Cells By Increasing Reactive Oxygen Species. 2018.
Precaución: Estas citas no son 100% exactas.